Side-by-side comparison of AI visibility scores, market position, and capabilities
National aggregate (crushed stone) producer with $6.6B FY2024 revenue; permitting barriers create durable pricing power; IIJA infrastructure spending multi-year tailwind; competes with Vulcan Materials.
Martin Marietta Materials is one of the nation's leading suppliers of building materials, including aggregates (crushed stone, sand, and gravel), cement, ready-mixed concrete, and asphalt—the essential bulk commodities upon which roads, bridges, buildings, and infrastructure are built. Spun off from Martin Marietta Corporation in 1993 and headquartered in Raleigh, North Carolina, the company trades on NYSE (MLM) and generated approximately $6.6 billion in net revenues for FY2024 under CEO Ward Nye, who has led Martin Marietta since 2010 and executed a long-term geographic expansion strategy that has doubled the company's revenue and market capitalization through acquisitions and organic pricing growth. The 2022 acquisition of Lehigh Hanson's Western operations from Heidelberg Materials for $2.3 billion added major aggregate reserves in Texas and Colorado, reinforcing Martin Marietta's Sun Belt and Rocky Mountain footprint.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.